PRODUCTS & SERVICES
Today we had the privilege to host Ludovit Odor, the Prime Minister of Slovakia, at MultiplexDX. We presented him with our diagnostic test Multiplex8+ and showed him our technology on screen and in our laboratories. He met our management team and scientific teams. We had a chance to discuss our mission and the next steps ahead of us as a company.
Having Prime Minister at MultiplexDX was an honor since he profoundly understands the importance of supporting innovations and young talents in our country.
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.